T

The human gut is not merely a digestive tube. It is a remarkably complex biological ecosystem that communicates continuously with almost every organ system.

The enteric microbiome can be regarded as a functional metabolic, immunological and neuroendocrine partner of the human body.

It influences how we digest food, extract energy, regulate immunity, respond to infections, maintain metabolic balance and communicate with the brain.

An important concept is that humans are not physiologically just human cells. We are a biological partnership between human cells and trillions of microorganisms.

However, the relationship is not always beneficial. Depending on the microbial species, their location, diet, host genetics and environmental conditions, the microbiome can protect us, remain neutral or contribute to disease.

Let’s examine this from a clinical and physiological perspective.

1. The gut microbiome as an additional metabolic organ

The human genome cannot independently digest all the complex carbohydrates and fibres we consume.

Gut microorganisms provide additional metabolic capabilities.

Three important products of bacterial fermentation are short-chain fatty acids (SCFAs):

• Acetate
• Propionate
• Butyrate

Their physiological functions are different. SCFA Major physiological function Butyrate Main energy source for colonocytes; supports epithelial barrier and anti-inflammatory signalling Propionate Participates in hepatic metabolism and glucose regulation Acetate Enters systemic circulation and contributes to lipid and energy metabolism

Why is butyrate particularly important?

The colonic epithelium depends substantially on butyrate for energy. Butyrate also influences gene expression through histone deacetylase inhibition and helps regulate inflammatory responses.

Thus, dietary fibre is not simply roughage. It is a substrate for microbial production of biologically active metabolites.

This explains why a fibre-poor diet can alter intestinal physiology even when caloric intake is adequate.

2. The microbiome and the immune system

The intestine represents one of the largest immunological interfaces in the body.

The gut-associated lymphoid tissue (GALT) contains specialised immune structures, including:

• Peyer’s patches
• Isolated lymphoid follicles
• Lamina propria immune cells
• Mesenteric lymph nodes

Gut microorganisms help the immune system distinguish between harmless substances and potential threats.

Three important mechanisms operate here:

A. Immune education

Microbial antigens and metabolites influence the differentiation of regulatory T cells (Tregs), Th17 cells and other immune populations.

Tregs help prevent excessive immune responses against harmless antigens and commensal microorganisms.

B. Colonisation resistance

Beneficial microorganisms compete with pathogens for nutrients and attachment sites. Some produce bacteriocins and other antimicrobial substances.

This helps prevent pathogens such as Clostridioides difficile from establishing themselves.

C. Intestinal barrier protection

The intestinal epithelium is protected by:

• Mucus produced by goblet cells.
• Tight-junction proteins such as occludin and claudins.
• Antimicrobial peptides.
• Secretory IgA.

Microbial metabolites, particularly butyrate, help maintain this protective environment.

When the barrier is disrupted, microbial products such as lipopolysaccharide (LPS) may cross the intestinal barrier and contribute to systemic inflammation.

3. The gut-brain axis: How the intestine communicates with the brain

Perhaps the most fascinating discovery in microbiome research is the bidirectional communication between the intestine and the brain.

This communication occurs through three major pathways:

• Neural pathway – particularly the vagus nerve.
• Endocrine pathway – gut hormones and the hypothalamic-pituitary-adrenal (HPA) axis.
• Immunological pathway – cytokines, microbial metabolites and immune signalling.

A. Neurotransmitters

Gut microorganisms can produce or influence several neuroactive substances. Substance Potential relevance GABA Inhibitory neurotransmission Serotonin Gastrointestinal motility, secretion and signalling Dopamine-related metabolites Neuroendocrine and metabolic signalling Tryptophan metabolites Immune regulation and neural signalling

An important clarification: approximately 90% of the body’s serotonin is produced in the gastrointestinal system, primarily by enterochromaffin cells.

However, peripheral serotonin does not normally cross the blood-brain barrier in significant quantities. Therefore, gut serotonin and brain serotonin are separate functional pools.

Microorganisms influence serotonin production indirectly through metabolites and interactions with enterochromaffin cells.

B. Vagus nerve communication

The vagus nerve provides an important communication channel between the intestine and the brain.

Microbial metabolites can stimulate intestinal sensory pathways, influencing:

• Appetite and satiety.
• Gastrointestinal motility.
• Stress responses.
• Autonomic nervous system activity.

This is one reason why intestinal disturbances can sometimes be associated with changes in mood and behaviour.

C. Microbiome and stress

Experimental studies suggest that gut microbial composition can influence the HPA axis.

Animal experiments have demonstrated that alterations in early microbial colonisation can affect stress responses.

Human research is promising, but it has not yet established that dysbiosis independently causes anxiety or depression.

4. The microbiome and metabolic diseases

The gut microbiome influences the body’s energy balance and metabolic signalling.

A. Obesity and insulin resistance

Microbial metabolites influence:

• GLP-1 secretion.
• PYY secretion.
• Appetite regulation.
• Intestinal permeability.
• Inflammatory signalling.
• Glucose and lipid metabolism.

SCFAs can stimulate intestinal L-cells to release GLP-1 and PYY.

These hormones participate in appetite regulation, glucose homeostasis and gastrointestinal motility.

The relationship between obesity and microbiome composition is complex. It is not possible to diagnose obesity-related dysbiosis simply by measuring the Firmicutes-to-Bacteroidetes ratio.

B. Gut-liver axis

The liver and intestine maintain continuous communication through the portal circulation and bile acid metabolism.

Gut microorganisms:

• Transform primary bile acids into secondary bile acids.
• Influence cholesterol and lipid metabolism.
• Produce metabolites that reach the liver.
• Influence hepatic inflammatory pathways.

Disruption of this relationship has been associated with metabolic dysfunction-associated steatotic liver disease (MASLD).

C. Gut-heart axis

One interesting pathway involves trimethylamine N-oxide (TMAO).

Dietary choline and L-carnitine can be converted by intestinal microorganisms into trimethylamine (TMA).

The liver subsequently converts TMA into TMAO.

Elevated TMAO concentrations have been associated with cardiovascular risk.

However, association does not establish causation, and TMAO is influenced by kidney function, diet and other metabolic factors.

5. Microbiome and human diseases

The following table summarises some important clinical associations. Disease Microbiome-related mechanisms Ulcerative colitis Altered microbial composition, impaired barrier and immune dysregulation Crohn’s disease Reduced abundance of certain protective organisms and altered immune interactions IBS Altered microbial metabolism, gut-brain signalling and visceral sensitivity Obesity Altered energy metabolism and microbial signalling Type 2 diabetes Associations with microbial metabolites and metabolic inflammation MASLD Altered bile acid metabolism and gut-liver signalling Rheumatoid arthritis Possible microbial contribution to immune dysregulation Parkinson’s disease Altered intestinal microbiome, inflammation and gut-brain signalling Depression Associations involving inflammation, tryptophan metabolism and gut-brain communication

An important distinction: these are not all established causal relationships. In many diseases, microbiome changes may be a cause, consequence or both.

6. Can we modify the microbiome to improve health?

Yes. Diet is one of the most important modifiable influences on the intestinal microbiome.

Some practical approaches include:

1. Dietary fibre

• Whole grains.
• Vegetables.
• Fruits.
• Pulses and legumes.
• Nuts and seeds.

These provide substrates for beneficial microbial fermentation.

2. Fermented foods

Curd, yoghurt and other traditionally fermented foods can provide live microorganisms, depending on preparation and storage.

3. Dietary diversity

Consuming different plant foods provides different microbial substrates and may support microbial diversity.

4. Avoid unnecessary antibiotics

Antibiotics can significantly disturb microbial communities. They should be used when clinically indicated, not for routine digestive complaints.

5. Probiotics

Probiotics are not interchangeable. Their effects are strain-specific and condition-specific. A probiotic useful for antibiotic-associated diarrhoea may not be useful for IBS or inflammatory bowel disease.

7. Some important scientific corrections

Your original description is broadly sound, but several statements need qualification if you intend to use it in a medical article or lecture. Original concept Scientific clarification 70–80% of immune cells reside in GALT Frequently quoted, but the precise percentage varies with the definition and measurement of gut-associated immune tissue. Gut bacteria produce vitamin B12 Some bacteria synthesise cobalamin, but much of this is not necessarily bioavailable to humans. Gut microbial vitamin production cannot be relied upon to prevent deficiency. Butyrate and SCFAs cross the BBB Their brain effects are complex; direct passage and indirect immune, endocrine and neural mechanisms both matter. Lactobacillus produces GABA Certain strains do so in laboratory conditions; clinical neurological benefits are not established. Dysbiosis causes autoimmune diseases Evidence supports associations and possible mechanisms, but causality is established only in limited specific contexts. Firmicutes/Bacteroidetes ratio predicts obesity This ratio is inconsistent across studies and is not a validated clinical biomarker.

8. The bigger picture: The microbiome as a sixth physiological system

I would propose looking at the enteric microbiome through six interconnected physiological functions:

The six dimensions of the human microbiome

1. Metabolic system

Digestion, fermentation, energy extraction and vitamin metabolism.

2. Immunological system

Immune education, tolerance and protection against pathogens.

3. Neuroendocrine system

Gut-brain communication, neurotransmitter signalling and stress responses.

4. Hepatometabolic system

Bile acid metabolism, lipid regulation and gut-liver signalling.

5. Barrier system

Mucosal protection, epithelial integrity and control of microbial translocation.

6. Cardiovascular and systemic signalling

Microbial metabolites influencing vascular, inflammatory and metabolic pathways.

My central observation: The gut microbiome should not be considered merely a collection of bacteria responsible for digestion. It is an active biological ecosystem that participates in maintaining human homeostasis.

The next frontier of medicine may involve understanding not just the human genome, but the interaction between the human genome, microbial genome, diet and environment.

This is the emerging concept of holobiont biology: the human being functioning in association with its microbial partners.

It is important, however, not to call the microbiome a separate human organ in the anatomical sense. It is better described as a distributed functional ecosystem with organ-like physiological effects.